These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7530922)

  • 1. Does protein kinase C play a role in ischemic preconditioning in rat hearts?
    Li Y; Kloner RA
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H426-31. PubMed ID: 7530922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of protein kinase in C ischemic/reperfused preconditioned isolated rat hearts.
    Tosaki A; Maulik N; Engelman DT; Engelman RM; Das DK
    J Cardiovasc Pharmacol; 1996 Nov; 28(5):723-31. PubMed ID: 8945687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cardioprotective effects of ischemic 'preconditioning' are not mediated by adenosine receptors in rat hearts.
    Li Y; Kloner RA
    Circulation; 1993 May; 87(5):1642-8. PubMed ID: 8491020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C is involved in cardioprotective effects of ischemic preconditioning on infarct size and ventricular arrhythmia in rats in vivo.
    Matsumura K; Komori S; Takusagawa M; Osada M; Tanabe F; Itoh M; Tamura K
    Mol Cell Biochem; 2000 Nov; 214(1-2):39-45. PubMed ID: 11195788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine deaminase inhibition is not cardioprotective in the rat.
    Li Y; Kloner RA
    Am Heart J; 1993 Dec; 126(6):1293-8. PubMed ID: 8249784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemic preconditioning attenuates apoptosis through protein kinase C in rat hearts.
    Okamura T; Miura T; Iwamoto H; Shirakawa K; Kawamura S; Ikeda Y; Iwatate M; Matsuzaki M
    Am J Physiol; 1999 Nov; 277(5):H1997-2001. PubMed ID: 10564156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase C. Its role in ischemic preconditioning in the rat.
    Speechly-Dick ME; Mocanu MM; Yellon DM
    Circ Res; 1994 Sep; 75(3):586-90. PubMed ID: 8062429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes.
    Miura T; Miura T; Kawamura S; Goto M; Sakamoto J; Tsuchida A; Matsuzaki M; Shimamoto K
    Cardiovasc Res; 1998 Mar; 37(3):700-9. PubMed ID: 9659454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of tyrosine kinase and protein kinase C in infarct size limitation by repetitive ischemic preconditioning in the rat.
    Tanno M; Tsuchida A; Nozawa Y; Matsumoto T; Hasegawa T; Miura T; Shimamoto K
    J Cardiovasc Pharmacol; 2000 Mar; 35(3):345-52. PubMed ID: 10710117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of preconditioning on reperfusion arrhythmias, myocardial functions, formation of free radicals, and ion shifts in isolated ischemic/reperfused rat hearts.
    Tosaki A; Cordis GA; Szerdahelyi P; Engelman RM; Das DK
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):365-73. PubMed ID: 7515978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model?
    Przyklenk K; Sussman MA; Simkhovich BZ; Kloner RA
    Circulation; 1995 Sep; 92(6):1546-57. PubMed ID: 7664439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox signaling at reperfusion is required for protection from ischemic preconditioning but not from a direct PKC activator.
    Liu Y; Yang XM; Iliodromitis EK; Kremastinos DT; Dost T; Cohen MV; Downey JM
    Basic Res Cardiol; 2008 Jan; 103(1):54-9. PubMed ID: 17999029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential role of PI3K/Akt pathway in the infarct size limitation and antiarrhythmic protection in the rat heart.
    Ravingerová T; Matejíková J; Neckár J; Andelová E; Kolár F
    Mol Cell Biochem; 2007 Mar; 297(1-2):111-20. PubMed ID: 17016676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective effects of ischaemic preconditioning are not mediated by prostanoids.
    Li Y; Kloner RA
    Cardiovasc Res; 1992 Mar; 26(3):226-31. PubMed ID: 1423416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can ischemic preconditioning protect against hypoxia-induced damage? Studies of contractile function in isolated perfused rat hearts.
    Cave AC; Horowitz GL; Apstein CS
    J Mol Cell Cardiol; 1994 Nov; 26(11):1471-86. PubMed ID: 7897671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial actions of preconditioning and stretch on postischemic contractile function of isolated working rat heart: effects of staurosporine.
    Obadia JF; Ovize M; Maupoil V; Terrand J; Abadie C; Ovize A; Andre-Fouët X; Minaire Y; Rochette L
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):191-6. PubMed ID: 9269946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acetaminophen on myocardial infarct size in rats.
    Dai W; Kloner RA
    J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):277-84. PubMed ID: 14740077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential antiarrhythmic effects of exogenous and endogenous bradykinin in the ischaemic rat heart in vivo.
    Sun W; Wainwright CL
    Coron Artery Dis; 1994 Jun; 5(6):541-50. PubMed ID: 7952414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preconditioning protects ischemic rabbit heart by protein kinase C activation.
    Ytrehus K; Liu Y; Downey JM
    Am J Physiol; 1994 Mar; 266(3 Pt 2):H1145-52. PubMed ID: 8160817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK.
    Weber NC; Toma O; Wolter JI; Obal D; Müllenheim J; Preckel B; Schlack W
    Br J Pharmacol; 2005 Jan; 144(1):123-32. PubMed ID: 15644876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.